Paper37515003
Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA.
Matthews DA and 3 others. Vaccines (Basel), 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA. Papers, record 37515003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37515003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/N023668/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23142869 | De novo derivation of proteomes from transcriptomes for transcript and protein identification. | Nat Methods | 2012 | https://conductscience.org/library/papers/23142869 | PubMed |
| 2 | 24889252 | A new look at adenovirus splicing. | Virology | 2014 | https://conductscience.org/library/papers/24889252 | PubMed |
| 3 | 22808149 | A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. | PLoS One | 2012 | https://conductscience.org/library/papers/22808149 | PubMed |
| 4 | 14573794 | Genetic content and evolution of adenoviruses. | J Gen Virol | 2003 | https://conductscience.org/library/papers/14573794 | PubMed |
| 5 | 35155043 | Neurological Conditions Following COVID-19 Vaccinations: Chance or Association? | Cureus | 2022 | https://conductscience.org/library/papers/35155043 | PubMed |
| 6 | 24646598 | Vaccines that stimulate T cell immunity to HIV-1: the next step. | Nat Immunol | 2014 | https://conductscience.org/library/papers/24646598 | PubMed |
| 7 | 35746566 | Adenovirus DNA Polymerase Loses Fidelity on a Stretch of Eleven Homocytidines during Pre-GMP Vaccine Preparation. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35746566 | PubMed |
| 8 | 902310 | An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. | Cell | 1977 | https://conductscience.org/library/papers/902310 | PubMed |
| 9 | 29750242 | Minimap2: pairwise alignment for nucleotide sequences. | Bioinformatics | 2018 | https://conductscience.org/library/papers/29750242 | PubMed |
| 10 | 32170151 | Deep splicing plasticity of the human adenovirus type 5 transcriptome drives virus evolution. | Commun Biol | 2020 | https://conductscience.org/library/papers/32170151 | PubMed |
| 11 | 754866 | A spliced sequence at the 5'-terminus of adenovirus late mRNA. | Brookhaven Symp Biol | 1977 | https://conductscience.org/library/papers/754866 | PubMed |
| 12 | 24374965 | Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens. | Mol Ther | 2014 | https://conductscience.org/library/papers/24374965 | PubMed |
| 13 | 36095031 | Novel viral splicing events and open reading frames revealed by long-read direct RNA sequencing of adenovirus transcripts. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/36095031 | PubMed |
| 14 | 22513323 | Lessons learned from HIV-1 vaccine trials: new priorities and directions. | Nat Immunol | 2012 | https://conductscience.org/library/papers/22513323 | PubMed |
| 15 | 36229342 | Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial. | EBioMedicine | 2022 | https://conductscience.org/library/papers/36229342 | PubMed |
| 16 | 34169114 | Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/34169114 | PubMed |
| 17 | 22275401 | Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector. | J Infect Dis | 2012 | https://conductscience.org/library/papers/22275401 | PubMed |
| 18 | 31613649 | Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials. | Expert Rev Vaccines | 2019 | https://conductscience.org/library/papers/31613649 | PubMed |
| 19 | 29334379 | Highly parallel direct RNA sequencing on an array of nanopores. | Nat Methods | 2018 | https://conductscience.org/library/papers/29334379 | PubMed |
| 20 | 37294928 | Reactogenicity and Peak Anti-RBD-S1 IgG Concentrations in Individuals with No Prior COVID-19 Infection Vaccinated with Different SARS-CoV-2 Vaccines. | Lab Med | 2024 | https://conductscience.org/library/papers/37294928 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42048387 | Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42048387 | PubMed |
| 40388952 | Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa. | Lancet Microbe | 2025 | https://conductscience.org/library/papers/40388952 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37515003
GET https://conductscience.org/api/papers/v1/37515003/references?page=2